Stockreport

Puma Bio up 5% after hours on Nerlynx nod in Canada [Seeking Alpha]

Puma Biotechnology Inc  (PBYI) 
Last puma biotechnology inc earnings: 2/20 04:07 pm Check Earnings Report
US:NYSE Investor Relations: pumabiotechnology.com/ir.html
PDF Health Canada approves Puma Biotechnology's (NASDAQ: PBYI ) NERLYNX (neratinib) for the extended adjuvant treatment of women with early-stage hormone receptor- [Read more]